OpenToolslogo
ToolsExpertsSubmit a Tool
AdvertiseLearn AI
  1. home
  2. news
  3. tags
  4. pharmaceuticals

pharmaceuticals

10+ articles
AIAI DeploymentAI DevelopmentAI HealthcareAI Startups
Loading news...

Related Topics

AIAI DeploymentAI DevelopmentAI HealthcareAI StartupsAI in MedicineAlphaFoldArtificial IntelligenceAutomotiveBiotech

Most Read

1
Tech Stocks Propel Market Rally Amidst Google’s AI Leap and Novo Nordisk's Regulatory Win
2
AI Steps Up: Revolutionizing Drug Safety Amid Pharma's Talent Crisis
3
Google Ventures into Human Trials with AI-Designed Drugs
4
Unearthing AI's Role in Drug Discovery: A Breakthrough or Just Hype?
5
Biotech Firm's AI Lung Disease Breakthrough Amid Hong Kong IPO

Stay in the loop

Weekly updates on tools, models, and the companies building them.

Subscribe free

Footer

Company name

The right AI tool is out there. We'll help you find it.

LinkedInX

Knowledge Hub

  • News
  • Resources
  • Newsletter
  • Blog
  • AI Tool Reviews
  • YouTube Summary
  • YouTube Transcript Generator

Industry Hub

  • AI Companies
  • AI Tools
  • AI Models
  • MCP Servers
  • AI Tool Categories
  • Top AI Use Cases

For Builders

  • Submit a Tool
  • Experts & Agencies
  • Advertise
  • Compare Tools
  • Favourites

Legal

  • Privacy Policy
  • Terms of Service

© 2026 OpenTools - All rights reserved.

Tech Stocks Propel Market Rally Amidst Google’s AI Leap and Novo Nordisk's Regulatory Win

The stock market soared on November 24, 2025, driven by tech and pharma sectors. Tech stocks, led by Google's Gemini 3 AI announcement, fueled the Nasdaq's rise. Novo Nordisk’s resolution of semaglutide shortages boosted its shares, underscoring a day marked by innovation and regulatory milestones.

Nov 25
Tech Stocks Propel Market Rally Amidst Google’s AI Leap and Novo Nordisk's Regulatory Win

AI Steps Up: Revolutionizing Drug Safety Amid Pharma's Talent Crisis

In the face of a talent shortfall, the pharmaceutical industry is turning to AI for drug safety workflows. By utilizing AI technologies like machine learning and natural language processing, the sector is enhancing efficiency in pharmacovigilance processes, tackling regulatory demands, and addressing the scarcity of skilled professionals. The integration of AI in drug safety promises quicker data processing, minimal manual tasks, and improved risk assessments, setting a new standard in the pharma industry.

Sep 16
AI Steps Up: Revolutionizing Drug Safety Amid Pharma's Talent Crisis

Google Ventures into Human Trials with AI-Designed Drugs

Google is taking a bold step in the pharmaceutical industry as it prepares to begin human trials of drugs designed using artificial intelligence. This pioneering move could revolutionize how new medicines are developed and tested, significantly shortening the time from discovery to market. Stay tuned as we delve into the potential impacts and the future of AI in healthcare.

Jul 8
Google Ventures into Human Trials with AI-Designed Drugs

Unearthing AI's Role in Drug Discovery: A Breakthrough or Just Hype?

AI systems are rapidly transforming the pharmaceutical industry by predicting and designing novel drug candidates in record time. Is this the breakthrough we're all waiting for, or just another overhyped buzzword?

Jun 10
Unearthing AI's Role in Drug Discovery: A Breakthrough or Just Hype?

Biotech Firm's AI Lung Disease Breakthrough Amid Hong Kong IPO

A biotech company has announced a major AI-driven breakthrough in discovering new drugs for lung disease, coinciding with its third attempt at a Hong Kong IPO.

Jun 5
Biotech Firm's AI Lung Disease Breakthrough Amid Hong Kong IPO

OpenAI and FDA in Secret Talks: AI Set to Transform Drug Evaluations?

OpenAI and the FDA are allegedly in discussions about using artificial intelligence for drug evaluations, potentially revolutionizing how drugs are assessed and approved. This collaboration could accelerate the drug approval process while ensuring safety and efficacy, a big win for healthcare innovation.

May 8
OpenAI and FDA in Secret Talks: AI Set to Transform Drug Evaluations?

Ex-DeepMind Scientist Embarks on AI-Driven Drug Discovery Adventure!

A former DeepMind scientist has launched a pioneering venture focused on leveraging AI to innovate the drug discovery process. Building on successes like AlphaFold, the project aims to revolutionize pharmaceutical development by expediting timelines and cutting costs. As the AI drug discovery market expands, this initiative highlights the growing intersection of technology and healthcare.

Feb 13
Ex-DeepMind Scientist Embarks on AI-Driven Drug Discovery Adventure!

Trump's Latest Tariff Threat Targets Computer Chips and Semiconductors

Former President Trump's recent announcement to impose tariffs on foreign-produced computer chips, semiconductors, and pharmaceuticals aims to reinforce his campaign promise of bringing essential goods production back to the United States. While this move could reshape global tech industry dynamics, it also risks triggering economic and diplomatic tensions, particularly with key Asian allies.

Jan 28
Trump's Latest Tariff Threat Targets Computer Chips and Semiconductors

LandingLens Revolutionizes AI with No-Code Computer Vision Platform

Landing AI has unveiled LandingLens, a groundbreaking deep-learning computer vision platform that empowers users to develop and deploy AI vision projects without needing coding skills. By focusing on data-centric AI, the platform improves accuracy with smaller datasets, making it an ideal solution for industries ranging from automotive to pharmaceuticals. With its no-code interface and scalable deployment options, LandingLens sets a new standard in the ease and accessibility of AI technology.

Jan 25
LandingLens Revolutionizes AI with No-Code Computer Vision Platform

Google's AI Set to Decipher Doctor's Scrawls: A Prescription for Precision!

Google has unveiled an innovative AI tool that aims to decode doctors' notoriously difficult handwriting. Announced at the Google for India conference, the technology is currently in a research prototype phase and allows users to upload or photograph prescriptions. The AI then identifies and highlights medications, aiding pharmacists and accelerating the digitization of medical documents. However, it's designed to assist, not replace, medical professionals. While the public eagerly awaits its release, concerns about accuracy and liability remain.

Jan 17
Google's AI Set to Decipher Doctor's Scrawls: A Prescription for Precision!